KRM Ayurveda, established in 2019, operates an integrated network of Ayurveda-based hospitals and clinics across multiple cities in India while also serving patients internationally through telemedicine consultation and sales channels. The Company currently manages six hospitals and five clinics at strategic locations. Although it initially commenced operations as a specialized kidney care hospital, it has gradually broadened its medical scope to provide holistic treatment for multiple health conditions, including liver cirrhosis, diabetes, fatty liver, and arthritis, among others. Over time, KRM Ayurveda has strengthened its global outreach through digital healthcare services, enabling wider patient access beyond India. In addition to clinical services, the Company is actively engaged in the trading of Ayurvedic medicines, therapeutic oils, and nutritional supplements, reinforcing its commitment to traditional, preventive, and wellness-oriented healthcare solutions.
Price Band₹128 - ₹135 |
Dates21 Jan - 23 Jan |
GMP₹21 (15.56%) |
Subscriptions72.33 times |
Issue Size₹77.49 Crs |
21 Jan 26
23 Jan 26
27 Jan 26
28 Jan 26
28 Jan 26
29 Jan 26
Price Band₹128 - ₹135 |
Listing AtNSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹77.49 Cr (0.57 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹77.49 Cr (0.57 Cr Shares) |
Face Value₹10 per equity share |
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
2
2,000
2,70,000
Maximum
2
2,000
2,70,000
|
|||
| Small HNI |
Minimum
3
3,000
4,05,000
Maximum
7
7,000
9,45,000
|
|||
| Big HNI |
Minimum
8
8,000
10,80,000
|
|||
Updated as on 23-Jan-2026 19:00:11 hrs
| Investor Category | Subscription (times) | Shares Offered | Shared Bid |
|---|---|---|---|
| QIB | 61.52 | 10,62,000 | 6,53,38,000 |
| NII | 132.53 | 8,01,000 | 10,61,59,000 |
| bNII | 163.24 | 5,34,000 | 8,71,69,000 |
| sNII | 71.12 | 2,67,000 | 1,89,90,000 |
| Individual Investor | 52.64 | 18,66,000 | 9,82,22,000 |
| Total | 72.33 | 37,29,000 | 26,97,19,000 |
The estimated Grey Market Premium of KRM Ayurveda IPO is ₹21 per share (15.56%)
| Particulars | Allocation |
|---|---|
| QIB | Not more than 50% of Net Offer |
| NII | Not less than 15% of Net Offer |
| Retail | Not less than 35% of Net Offer |
| Market Maker | 4,24,000 EQ. Shares |
| Particulars | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue | 48.36 | 76.55 | 67.16 | 89.29 |
| PAT | 8.14 | 12.10 | 3.41 | 7.60 |
| Net Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Borrowings | 25.07 | 31.20 | 23.18 | 19.87 |
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| NAV (₹) | 25.64 | 1,602.40 | 7,852.34 | 5,577.54 |
| EPS (₹) | 5.24 | 8.06 | 2.27 | 5.07 |
The financial information presented is on a consolidated basis.
| KPI | VALUES |
|---|---|
| EBITDA | 24.96% |
| ROE | 67.86% |
| ROCE | 43.33% |
| PE Ratio | 16.75 |
| PB Ratio | 0.08 |
| Mkt Cap (in Crs.) | 287.02 |
| Particulars | KRM Ayurveda | Jeena Sikho Lifecare | Vaidya Sane Ayurved |
|---|---|---|---|
| Revenue | 76.55 | 469.07 | 87.11 |
| PAT | 12.10 | 90.73 | 4.90 |
| EPS (₹) | 5.24 | 8.86 | 3.07 |
| NAV (₹) | 25.64 | 142.24 | 59.85 |
| RONW | 27.13% | 31.28% | 5.12% |
| EBITDA | 24.96% | 26.64% | 15.50% |
| PAT Mrgn | 15.80% | 19.34% | 5.62% |
| PE Ratio | 16.75 | 76.58 | 93.20 |
All information pertains to FY 2024-25. PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of December 31, 2025 for Peers
| Particulars | KRM Ayurveda |
|---|---|
| Revenue | 76.55 |
| PAT | 12.10 |
| EPS (₹) | 5.24 |
| NAV (₹) | 25.64 |
| RONW | 27.13% |
| EBITDA | 24.96% |
| PAT Mrgn | 15.80% |
| PE Ratio | 16.75 |
| Jeena Sikho Lifecare | Vaidya Sane Ayurved |
|---|---|
| 469.07 | 87.11 |
| 90.73 | 4.90 |
| 8.86 | 3.07 |
| 142.24 | 59.85 |
| 31.28% | 5.12% |
| 26.64% | 15.50% |
| 19.34% | 5.62% |
| 76.58 | 93.20 |
All information pertains to FY 2024-25. PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of December 31, 2025 for Peers
| Name | Shareholding |
|---|---|
| Puneet Dhawan | 90.80% |
| Others | 1.36% |
| Total | 92.16% |
| Name | Designation |
|---|---|
| Puneet Dhawan | MD |
| Avtar Rana | CFO |
Name: Krm Ayurveda Limited
Address: A-16 G T Karnal road Industrial Area, North West, Delhi, Delhi, India-110033.
Number: 9289101700
Email: compliance@krmayurveda.com
Website: www.krmayurvedaindia.com
Frequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
KRM Ayurveda IPO is a SME IPO having an issue size of Rs. ₹77.49 Crs. KRM Ayurveda IPO is priced at ₹128 - ₹135 per share. The issue opens on 21 Jan 26 and closes on 23 Jan 26.
KRM Ayurveda IPO opens on 21 Jan 26 and closes on 23 Jan 26.
The estimated Grey Market Premium of KRM Ayurveda IPO is ₹21 per share (15.56%).
The minimum lot size of KRM Ayurveda IPO is 1000 shares & the minimum application amount is Rs. 135000.
The allotment date of KRM Ayurveda IPO is 27 Jan 26.
The listing date of KRM Ayurveda IPO is 29 Jan 26.
KRM Ayurveda IPO is subscribed 72.33 times.
KRM Ayurveda IPO is priced at ₹128 - ₹135 per share.
Click the allotment link on KRM Ayurveda IPO page of IPO360.